227 related articles for article (PubMed ID: 21344432)
1. When to manage level V in head and neck carcinoma?
Naiboğlu B; Karapinar U; Agrawal A; Schuller DE; Ozer E
Laryngoscope; 2011 Mar; 121(3):545-7. PubMed ID: 21344432
[TBL] [Abstract][Full Text] [Related]
2. [The sentinel node concept in head and neck squamous cell carcinoma--a critical analysis in 100 patients].
Werner JA; Dünne AA; Ramaswamy A; Brandt D; Külkens C; Folz BJ; Moll R; Lippert BM
Laryngorhinootologie; 2002 Jan; 81(1):31-9. PubMed ID: 11845400
[TBL] [Abstract][Full Text] [Related]
3. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
Lim YC; Koo BS; Lee JS; Choi EC
Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
[TBL] [Abstract][Full Text] [Related]
4. Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
Richard C; Prevot N; Timoshenko AP; Dumollard JM; Dubois F; Martin C; Prades JM
Acta Otolaryngol; 2010 Dec; 130(12):1421-4. PubMed ID: 20735322
[TBL] [Abstract][Full Text] [Related]
5. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of loco-regional lymph nodes in neoplasms of the head and neck: strategies in clinical N+].
Piazza C; Redaelli De Zinis LO; Antonelli AR
Suppl Tumori; 2002; 1(3):S45-9. PubMed ID: 12415788
[No Abstract] [Full Text] [Related]
7. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
[TBL] [Abstract][Full Text] [Related]
8. The role of selective neck dissection in pathological N1 squamous cell carcinomas of the head and neck.
Yıldırım T; Ozmen OA; Erişen L; Kasapoğlu F; Coşkun H; Basut O; Onart S; Hızalan I
Kulak Burun Bogaz Ihtis Derg; 2011; 21(2):63-9. PubMed ID: 21417967
[TBL] [Abstract][Full Text] [Related]
9. Selective neck dissection for N0 and N1 oral cavity and oropharyngeal cancer: are skip metastases a real danger?
Lodder WL; Sewnaik A; den Bakker MA; Meeuwis CA; Kerrebijn JD
Clin Otolaryngol; 2008 Oct; 33(5):450-7. PubMed ID: 18983378
[TBL] [Abstract][Full Text] [Related]
10. Nodal yield in neck dissection and the likelihood of metastases.
Agrama MT; Reiter D; Cunnane MF; Topham A; Keane WM
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):185-90. PubMed ID: 12601312
[TBL] [Abstract][Full Text] [Related]
11. When to address level I lymph nodes in neck dissections?
Ozer E; Karapinar U; Ryoo C; Agrawal A; Schuller DE
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):355-8. PubMed ID: 20172380
[TBL] [Abstract][Full Text] [Related]
12. [Reconstruction of accessory nerve defects with sternocleidomastoid muscle-great auricular nerve flap].
Guo CB; Zhang Y; Zou LD; Mao C; Peng X; Yu GY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Nov; 39(6):445-8. PubMed ID: 15854310
[TBL] [Abstract][Full Text] [Related]
13. The relationship of cervical lymph node metastases to primary sites of carcinoma of the upper aerodigestive tract: a pathological study.
Cole I; Hughes L
Aust N Z J Surg; 1997 Dec; 67(12):860-5. PubMed ID: 9451342
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma.
Lohuis PJ; Klop WM; Tan IB; van Den Brekel MW; Hilgers FJ; Balm AJ
Am J Surg; 2004 Feb; 187(2):295-9. PubMed ID: 14769324
[TBL] [Abstract][Full Text] [Related]
15. Neck dissection: current concepts and future directions.
Rigual NR; Wiseman SM
Surg Oncol Clin N Am; 2004 Jan; 13(1):151-66. PubMed ID: 15062367
[TBL] [Abstract][Full Text] [Related]
16. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of the sentinel lymph node of patients with laryngeal and hypopharyngeal carcinomas].
Fang J; Wei X; Li S; Wang C; Tian A; Tao Y; Sun X; Zou S; Li M; Cai S; Luan X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):244-6. PubMed ID: 12761986
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
Lim YC; Lee JS; Choi EC
Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic selective neck dissection: a 25-year review.
Muzaffar K
Laryngoscope; 2003 Sep; 113(9):1460-5. PubMed ID: 12972914
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma.
Stoeckli SJ; Pfaltz M; Steinert H; Schmid S
Laryngoscope; 2002 Jan; 112(1):111-5. PubMed ID: 11802047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
